GlassScriptPhysician profile
Syed A Rizvi
NPI 1972639003
$3,452.91
in general payments reported to CMS, 2019-2025
35 companies · $266 in 2025
The $266 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,855 · 2020: $91.58 · 2021: $202 · 2022: $380 · 2023: $384 · 2024: $274 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841 · Education: $83.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.93 |
| Education | $83.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $1,009.37 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $474.57 | 2019-2025 | Jardiance, Synjardy |
| Novo Nordisk INC | $299.33 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Ibsa Pharma INC. | $290.45 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $165.39 | 2019-2021 | |
| Amgen INC. | $136.59 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $135.38 | 2019-2025 | |
| Lilly USA, LLC | $111.39 | 2019-2024 | Jardiance |
| Radius Health, INC. | $105.78 | 2020-2023 | Tymlos |
| Shire North American Group INC | $79.88 | 2019 | |
| Abbvie INC. | $77.23 | 2019-2024 | |
| Amneal Pharmaceuticals LLC | $59.67 | 2023-2025 | Unithroid |
| Aimmune Therapeutics, INC. | $51.66 | 2024-2025 | Zenpep |
| Medtronic, INC. | $50.35 | 2021-2024 | Minimed 770g, Minimed 780g |
| Antares Pharma, INC. | $48.28 | 2022-2023 | Tlando, Xyosted, Nocdurna |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Rizvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.